AKT1 and cancer: In addition to the greater ability in degrading pRB, we demonstrated for the first time that the HPV58E7 T20I/G63S attains a greater ability to promote cancer progression to eventual carcinoma than the prototype and other natural variants through AKT and K-Ras/ERK activation.